Campbell & CO Investment Adviser LLC Raises Holdings in Sabra Healthcare REIT, Inc. $SBRA

Key Points

• Campbell & CO Investment Adviser LLC significantly increased its stake in Sabra Healthcare REIT by acquiring 68,246 shares, raising its total to 91,936 shares valued at approximately $1.6 million.
• Analyst ratings for Sabra Healthcare REIT have improved, with price targets raised by multiple firms, including BMO Capital Markets and JMP Securities, now placing targets between $20.00 and $22.00.
• Sabra Healthcare REIT recently announced a quarterly dividend of $0.30, reflecting an annualized yield of 6.2%, with a noted dividend payout ratio of 157.89%.

Campbell & CO Investment Adviser LLC lifted its position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 288.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 91,936 shares of the real estate investment trust's stock after buying an additional 68,246 shares during the quarter. Campbell & CO Investment Adviser LLC's holdings in Sabra Healthcare REIT were worth $1,606,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the business. Nuveen LLC acquired a new position in shares of Sabra Healthcare REIT during the 1st quarter worth about $61,791,000. Jefferies Financial Group Inc. boosted its position in shares of Sabra Healthcare REIT by 7,196.8% during the 1st quarter. Jefferies Financial Group Inc. now owns 1,466,000 shares of the real estate investment trust's stock worth $25,611,000 after acquiring an additional 1,445,909 shares in the last quarter. Northern Trust Corp boosted its position in shares of Sabra Healthcare REIT by 27.7% during the 4th quarter. Northern Trust Corp now owns 4,169,385 shares of the real estate investment trust's stock worth $72,214,000 after acquiring an additional 905,466 shares in the last quarter. Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in shares of Sabra Healthcare REIT during the 4th quarter worth about $14,241,000. Finally, Wellington Management Group LLP boosted its position in shares of Sabra Healthcare REIT by 33.7% during the 4th quarter. Wellington Management Group LLP now owns 3,205,042 shares of the real estate investment trust's stock worth $55,511,000 after acquiring an additional 808,207 shares in the last quarter. 99.40% of the stock is owned by hedge funds and other institutional investors.

Sabra Healthcare REIT Stock Performance

SBRA stock traded down $0.20 during trading on Friday, hitting $19.11. The company had a trading volume of 2,586,825 shares, compared to its average volume of 2,461,291. The firm has a market cap of $4.58 billion, a PE ratio of 25.15, a price-to-earnings-growth ratio of 1.56 and a beta of 0.86. Sabra Healthcare REIT, Inc. has a 1-year low of $15.60 and a 1-year high of $20.03. The firm has a 50-day moving average price of $18.54 and a 200-day moving average price of $17.76. The company has a quick ratio of 4.80, a current ratio of 4.80 and a debt-to-equity ratio of 0.91.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last issued its quarterly earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.02. The firm had revenue of $189.15 million for the quarter, compared to analysts' expectations of $185.64 million. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.The firm's revenue for the quarter was up 7.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.36 EPS. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. On average, analysts expect that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current year.

Sabra Healthcare REIT Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 29th. Shareholders of record on Friday, August 15th will be given a dividend of $0.30 per share. The ex-dividend date is Friday, August 15th. This represents a $1.20 annualized dividend and a yield of 6.3%. Sabra Healthcare REIT's payout ratio is presently 157.89%.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the company. JMP Securities upped their price objective on Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a "market outperform" rating in a research report on Wednesday, August 6th. Wells Fargo & Company boosted their target price on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an "overweight" rating in a report on Wednesday. BMO Capital Markets boosted their target price on Sabra Healthcare REIT from $19.00 to $22.00 and gave the company a "market perform" rating in a report on Monday. Finally, Scotiabank boosted their target price on Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a "sector perform" rating in a report on Monday, June 23rd. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, Sabra Healthcare REIT has a consensus rating of "Moderate Buy" and an average target price of $20.43.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.